Aida Venado

Aida Venado

Auto-generated profile, based on publicly available information

Aida Venado

Division of Pulmonary and Critical Care, Department of Medicine, University of California San Francisco, San Francisco, CA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AVAida Venado
Aida Venado
CMCharles McCulloch
Charles McCulloch
JGJohn Greenland
John Greenland
PKPatricia Katz
Patricia Katz
ASAllison Soong
Allison Soong
JSJonathan P. Singer
Jonathan P. Singer

6 May 2020 in Thorax
Verified
Journal Article
Closed access
PDF file
AVAida Venado
Aida Venado
NKNicholas A Kolaitis
Nicholas A Kolaitis
CHChiung-Yu Huang
Chiung-Yu Huang
YGYing Gao
Ying Gao
DGDavid V Glidden
David V Glidden
JSJonathan P Singer
Jonathan P Singer
Background Lung transplantation and related medications are associated with pathobiological changes that can induce frailty, a state of decreased physiological reserve. Causes of persistent or emergent frailty after lung transplantation, and whether such transplant-related frailty is associated with key outcomes, are unknown. Methods Frailty and health-related quality of life (HRQL) were prospectively measured repeatedly for up to 3 years after lung transplantation. Frailty, quantified by the Short Physical Performance Battery (SPPB), was tested as a time-dependent binary and continuous predictor. The association of transplant-related frailty with HRQL and mortality was evaluated using mixed effects and Cox regression models, respectively, adjusting for age, sex, ethnicity, diagnosis, and for body mass index and lung function as time-dependent covariates. We tested the association between measures of body composition, malnutrition, renal dysfunction and immunosuppressants on the development of frailty using mixed effects models with time-dependent predictors and lagged frailty outcomes. Results Among 259 adults (56% male; mean age 55.9±12.3 years), transplant-related frailty was associated with lower HRQL. Frailty was also associated with a 2.5-fold higher mortality risk (HR 2.51; 95% CI 1.21 to 5.23). Further, each 1-point worsening in SPPB was associated, on average, with a 13% higher mortality risk (HR 1.13; 95% CI 1.04 to 1.23). Secondarily, we found that sarcopenia, underweight and obesity, malnutrition, and renal dysfunction were associated with the development of frailty after transplant. Conclusions Transplant-related frailty is associated with lower HRQL and higher mortality in lung recipients. Abnormal body composition, malnutrition and renal dysfunction may contribute to the development of frailty after transplant. Confirming the role of these potential contributors and developing interventions to mitigate frailty may improve lung transplant success.

1 February 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AOAnobel Y. Odisho
Anobel Y. Odisho
ALAndrew W. Liu
Andrew W. Liu
AMAli R. Maiorano
Ali R. Maiorano
MBM. Olivia A. Bigazzi
M. Olivia A. Bigazzi
EMEli Medina
Eli Medina
SHSteven R. Hays
Steven R. Hays

22 December 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
DCDaniel R. Calabrese
Daniel R. Calabrese
TTTasha Tsao
Tasha Tsao
MMMélia Magnen
Mélia Magnen
CVColin Valet
Colin Valet
YGYing Gao
Ying Gao
MLMark R. Looney
Mark R. Looney
Clinical outcomes after lung transplantation, a life-saving therapy for patients with end-stage lung diseases, are limited by primary graft dysfunction (PGD). PGD is an early form of acute lung injury with no specific pharmacologic therapies. Here, we present a large multicenter study of plasma and bronchoalveolar lavage (BAL) samples collected on the first posttransplant day, a critical time for investigations of immune pathways related to PGD. We demonstrated that ligands for NKG2D receptors were increased in the BAL from participants who developed severe PGD and were associated with increased time to extubation, prolonged intensive care unit length of stay, and poor peak lung function. Neutrophil extracellular traps (NETs) were increased in PGD and correlated with BAL TNF-α and IFN-γ cytokines. Mechanistically, we found that airway epithelial cell NKG2D ligands were increased following hypoxic challenge. NK cell killing of hypoxic airway epithelial cells was abrogated with NKG2D receptor blockade, and TNF-α and IFN-γ provoked neutrophils to release NETs in culture. These data support an aberrant NK cell/neutrophil axis in human PGD pathogenesis. Early measurement of stress ligands and blockade of the NKG2D receptor hold promise for risk stratification and management of PGD.

3 February 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
JSJonathan P. Singer
Jonathan P. Singer
CCCarolyn S. Calfee
Carolyn S. Calfee
KDKevin Delucchi
Kevin Delucchi
JDJoshua M. Diamond
Joshua M. Diamond
MAMichaela A. Anderson
Michaela A. Anderson
JCJason D. Christie
Jason D. Christie
Heterogeneous frailty pathobiology might explain the inconsistent associations observed between frailty and lung transplant outcomes. A Subphenotype analysis could refine frailty measurement. In a 3-center pilot cohort study, we measured frailty by the Short Physical Performance Battery, body composition, and serum biomarkers reflecting causes of frailty. We applied latent class modeling for these baseline data. Next, we tested class construct validity with disability, waitlist delisting/death, and early postoperative complications. Among 422 lung transplant candidates, 2 class model fit the best (P = .01). Compared with Subphenotype 1 (n = 333), Subphenotype 2 (n = 89) was characterized by systemic and innate inflammation (higher IL-6, CRP, PTX3, TNF-R1, and IL-1RA); mitochondrial stress (higher GDF-15 and FGF-21); sarcopenia; malnutrition; and lower hemoglobin and walk distance. Subphenotype 2 had a worse disability and higher risk of waitlist delisting or death (hazards ratio: 4.0; 95% confidence interval: 1.8-9.1). Of the total cohort, 257 underwent transplant (Subphenotype 1: 196; Subphenotype 2: 61). Subphenotype 2 had a higher need for take back to the operating room (48% vs 28%; P = .005) and longer posttransplant hospital length of stay (21 days [interquartile range: 14-33] vs 18 days [14-28]; P = .04). Subphenotype 2 trended toward fewer ventilator-free days, needing more postoperative extracorporeal membrane oxygenation and dialysis, and higher need for discharge to rehabilitation facilities (P ≤ .20). In this early phase study, we identified biological frailty Subphenotypes in lung transplant candidates. A hyperinflammatory, sarcopenic Subphenotype seems to be associated with worse clinical outcomes.

2 May 2022 in Thoracic Surgery Clinics
Verified
Journal Article
Closed access
AVAida Venado
Aida Venado
JKJasleen Kukreja
Jasleen Kukreja
JGJohn R. Greenland
John R. Greenland